Carotid Artery Stents Market Size & Growth Forecast 2027–2036, By Segments (Material, Mode of Delivery, Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Carotid Artery Stents Market size was estimated at USD 669.77 million in 2026 and is projected to grow at a 2.85% CAGR from 2027 to 2036, exceeding USD 887.09 million by 2036. The industry revenue for 2027 is assessed at USD 685.84 million.
Get more details on this report
Request Free Sample ReportCarotid Artery Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 41.87% share in 2026, supported by established vascular care pathways, advanced hospital infrastructure, and strong adoption of minimally invasive stroke-prevention procedures.
- Asia Pacific is projected to grow at a 3.42% CAGR as healthcare systems expand vascular care capabilities, improve access to interventional procedures, and strengthen stroke management infrastructure.
Segment Momentum
- Balloon-expandable stents held a 58.28% share in 2026 because physicians value their precise placement, controlled expansion, and dependable deployment during carotid artery interventions.
- Self-expanding stents are growing fastest as clinicians increasingly prefer devices that better adapt to vessel dynamics and provide greater flexibility after deployment.
Market Expansion Drivers
- Rising incidence of stroke and carotid artery disease driving demand for stenting procedures.
- Aging global population increasing prevalence of vascular plaque-related interventions.
- Development of drug-eluting and bioresorbable stents improving long-term treatment outcomes.
Leading Market Participants
- Leading players in the carotid artery stents market include Abbott Laboratories (United States), Boston Scientific Corporation (United States), Medtronic plc (Ireland), Terumo Corporation (Japan), Cardinal Health, Inc. (United States), MicroPort Scientific Corporation (China), Cordis (United States), Silk Road Medical, Inc. (United States), InspireMD, Inc. (United States), B. Braun Melsungen AG (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 669.77 million
- 2027 Estimated Market Size: USD 685.84 million.
- Projected Market Size: USD 887.09 million by 2036
- Growth Forecast: 2.85% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Metals (Material) | Balloon-expandable Stents (Mode of Delivery) | Drug Eluting Stents (Type) | Hospitals (End-use)
- Emerging Opportunity Segment: Polymers (Material) | Self-expanding Stents (Mode of Delivery) | Bioabsorbable Stents (Type) | Ambulatory Surgical Centers (End-use)
Market Growth Drivers and Industry Trends
Rising incidence of stroke and carotid artery disease driving demand for stenting procedures
The increasing burden of stroke and carotid artery disease is creating greater need for interventions that address narrowed or obstructed carotid vessels. The carotid artery stents market will benefit from rising procedural demand as stenting provides an established endovascular approach for treating patients requiring restoration of carotid artery blood flow.
Aging global population increasing prevalence of vascular plaque-related interventions
An expanding older population is associated with a greater prevalence of vascular conditions involving plaque accumulation and arterial narrowing. Within the carotid artery stents market, this demographic shift can increase the pool of patients requiring vascular assessment and intervention, supporting demand for stenting procedures in cases where carotid artery disease requires treatment.
Development of drug-eluting and bioresorbable stents improving long-term treatment outcomes
Technological progress in drug-eluting and bioresorbable stent designs is improving the treatment options available for carotid interventions. These developments will strengthen the carotid artery stents market by addressing the need for devices designed to support durable treatment outcomes, while advances in stent technology provide clinicians with additional options for managing vascular disease.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising incidence of stroke and carotid artery disease driving demand for stenting procedures | 2.20% | High | North America, Europe | High | Near Term |
| Aging global population increasing prevalence of vascular plaque-related interventions | 1.80% | High | Global | High | Mid Term |
| Development of drug-eluting and bioresorbable stents improving long-term treatment outcomes | 1.40% | High | Europe, North America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the carotid artery stents market with a 41.87% share in 2026, underpinned by advanced vascular care infrastructure, widespread availability of minimally invasive interventions, and strong clinical expertise in treating carotid artery disease. The region benefits from established screening and diagnosis pathways for vascular conditions, supporting timely identification of patients requiring intervention. Continued adoption of endovascular approaches, sophisticated hospital facilities, and access to advanced stent technologies further strengthen demand. In addition, emphasis on reducing procedural risks and improving outcomes for patients with carotid disease encourages healthcare providers to utilize increasingly specialized vascular devices.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, fueled by increasing cardiovascular disease awareness, improving diagnosis of vascular disorders, and rapid expansion of specialized healthcare infrastructure. Growing investment in hospitals and interventional facilities is enabling more patients to access minimally invasive vascular procedures, while physician training and technology adoption are expanding the capabilities of regional treatment centers. Rising healthcare expenditure and broader availability of advanced diagnostic imaging are also supporting earlier identification of carotid conditions. As healthcare systems increasingly prioritize sophisticated cardiovascular interventions and outcome-focused treatment, adoption of carotid artery stents is gaining momentum across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Protocol-led vascular careIn Germany, carotid artery stenting follows structured clinical protocols with strong emphasis on evidence-based vascular intervention. Hospitals rely on multidisciplinary evaluation, with utilization concentrated in specialized centers managing cerebrovascular disease under standardized and carefully monitored treatment pathways.
France 🇫🇷
Guideline-based utilizationIn France, utilization is shaped by national clinical guidelines and structured reimbursement systems. Adoption is generally reserved for carefully selected high-risk patients, with vascular teams prioritizing standardized protocols and long-term outcome monitoring in hospital settings.
Italy 🇮🇹
Selective vascular deploymentIn Italy, carotid artery stent usage remains selective, concentrated in larger hospitals and specialized vascular centers. Decision-making reflects regional resource differences and clinician preference for balancing procedural risk with minimally invasive treatment options in complex cases.
Japan 🇯🇵
Aging neurovascular demandIn Japan, rising prevalence of age-related vascular disease supports demand for carotid artery stenting among elderly high-risk patients. Clinicians prioritize safety, precision, and long-term outcomes within highly regulated hospital environments emphasizing conservative patient selection.
South Korea 🇰🇷
High-tech neuro adoptionIn South Korea, carotid artery stenting is increasingly integrated into advanced neurovascular programs in tertiary hospitals. Physicians emphasize minimally invasive stroke prevention supported by strong imaging infrastructure and rapid adoption of interventional technologies in high-capacity clinical centers.
United States 🇺🇸
Stroke intervention focusIn the U.S., carotid artery stents are primarily used in stroke prevention and treatment pathways for high-risk surgical patients. Adoption is influenced by clinical evidence, hospital stroke programs, and multidisciplinary vascular teams prioritizing minimally invasive alternatives to endarterectomy in complex cerebrovascular cases.
Segment Leadership and Growth Trends
Carotid Artery Stents Market Share (%), by Material, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMaterial Segment Analysis: Metals (Largest Segment) vs Polymers (Fastest-Growing Segment)
The metals segment led the carotid artery stents market, capturing an 84.36% share in 2026, owing to the established clinical use and mechanical reliability of metallic stent materials. Metals provide the strength and structural support required to maintain vessel patency while withstanding the physiological conditions within the carotid artery. Their proven performance, established physician familiarity, and compatibility with established stent designs continue to support their widespread utilization in carotid interventions.
Polymer-based materials are emerging as the fastest-growing segment as advances in biomaterial engineering improve their suitability for vascular applications. Polymers can offer greater flexibility and opportunities for tailored mechanical and biological properties, supporting the development of stents designed to improve vessel compatibility and procedural performance. Continued innovation in polymer formulations and growing interest in advanced biomaterials are strengthening their potential within carotid artery interventions.
Mode of Delivery Segment Analysis: Balloon-expandable Stents (Largest Segment) vs Self-expanding Stents (Fastest-Growing Segment)
Holding the largest share of the carotid artery stents market at 58.28% in 2026, balloon-expandable stents benefit from precise deployment and controlled expansion during vascular procedures. Their ability to provide accurate placement and consistent vessel support makes them valuable in interventions where positioning is critical. Established clinical familiarity and predictable deployment characteristics further contribute to their continued adoption among healthcare professionals.
Self-expanding stents are expected to experience the fastest growth, supported by their ability to adapt to vessel anatomy and maintain radial support after deployment. Their flexibility can facilitate treatment across anatomically challenging vascular pathways while reducing dependence on balloon-based expansion during placement. Ongoing improvements in stent design and increasing emphasis on minimally invasive vascular procedures are contributing to greater interest in self-expanding technologies.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Material | Metals, Polymers | Metals | Polymers |
| Mode of Delivery | Balloon-expandable Stents, Self-expanding Stents | Balloon-expandable Stents | Self-expanding Stents |
| Type | Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents | Drug Eluting Stents | Bioabsorbable Stents |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
Competitive Landscape and Market Positioning
Key companies in the carotid artery stents market:
1. Abbott Laboratories (United States)
2. Boston Scientific Corporation (United States)
3. Medtronic plc (Ireland)
4. Terumo Corporation (Japan)
5. Cardinal Health Inc. (United States)
6. MicroPort Scientific Corporation (China)
7. Cordis (United States)
8. Silk Road Medical Inc. (United States)
9. InspireMD Inc. (United States)
10. B. Braun Melsungen AG (Germany)
Advancements in neurovascular intervention technologies are driving the carotid artery stents market, with research aimed at improving stent design, safety, and long-term clinical performance. Technological innovation continues to support better treatment outcomes and procedural efficiency.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories (United States) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Terumo Corporation (Japan) | |||||||
| Cardinal Health Inc. (United States) | |||||||
| MicroPort Scientific Corporation (China) | |||||||
| Cordis (United States) | |||||||
| Silk Road Medical Inc. (United States) | |||||||
| InspireMD Inc. (United States) | |||||||
| B. Braun Melsungen AG (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Cordis | Oct-22 | Cordis acquired MedAlliance, a Swiss developer of drug-eluting balloon technology, to strengthen its interventional cardiovascular portfolio. The acquisition provides access to the SELUTION SLR platform, intended to address large-scale patient treatment opportunities and expand Cordis’ capabilities in drug-coated vascular intervention solutions. |
| Medtronic | Aug-22 | Medtronic launched the Onyx Frontier drug-eluting stent system, an advanced iteration of its Resolute Onyx platform. The system features an improved delivery mechanism designed to enhance acute performance and deliverability in complex coronary interventions, reinforcing Medtronic’s position in next-generation stent technologies. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Carotid Artery Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Indication | Symptomatic Carotid Stenosis, Asymptomatic Carotid Stenosis, Recurrent Stenosis |
| Lesion Location | Common Carotid Artery, Internal Carotid Artery, Carotid Bifurcation |
| Embolic Protection Compatibility | Distal Embolic Protection Compatible, Proximal Embolic Protection Compatible, Compatible with Both Protection Approaches |
Carotid Artery Stents Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Stroke Prevention Pathway Transformation Assessment |
|
| Physician Preference and Adoption Behavior Analysis |
|
| Emerging Market Commercialization Prioritization |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the carotid artery stents market?
What are the growth projections for the carotid artery stents industry?
How are evolving material preferences in carotid interventions influencing stent adoption across clinical practice?
What is driving the shift in deployment choice between balloon-expandable and self-expanding stents?
Why do balloon-expandable stents lead the carotid artery stents market?
Why are self-expanding stents the fastest-growing segment in the carotid artery stents market?
Why is North America the largest market for carotid artery stents?
What is driving carotid artery stent market growth in Asia Pacific?
Which companies are driving growth in the carotid artery stents landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization